Francesco Bianchi net worth and biography

Francesco Bianchi Biography and Net Worth

Director of LivaNova

Francesco Bianchi has served as the Chairman of Seven Capital Partners S.r.l., a financial consulting firm, since June 2018. He previously served as the Chief Executive Officer of Seven Capital Partners and has been with the firm since 2013. Mr. Bianchi has 30 years of mergers and acquisitions and strategic advisory experience working for well-recognized international financial institutions including JPMorgan Chase (Paris), Morgan Grenfell (London), Citi (Milan) and Bankers Trust (Milan), where he served in various roles including general manager and head of the mergers and acquisitions and corporate finance division. He also headed the strategic planning division of Banca-Intesa S.p.A. in Italy and abroad. Mr. Bianchi earned a degree in economic sciences with honors from the University of Florence and is a chartered accountant.

Mr. Bianchi is an audit committee financial expert and has an extensive professional background working in strategy and mergers and acquisitions.

What is Francesco Bianchi's net worth?: The estimated net worth of Francesco Bianchi is at least $266,730.12 as of December 11th, 2024. Mr. Bianchi owns 7,522 shares of LivaNova stock worth more than $266,730 as of April 22nd. This net worth estimate does not reflect any other investments that Mr. Bianchi may own. Learn More about Francesco Bianchi's net worth.
How do I contact Francesco Bianchi?: The corporate mailing address for Mr. Bianchi and other LivaNova executives is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. LivaNova can also be reached via phone at 442033250660 and via email at investor.relations@livanova.com. Learn More on Francesco Bianchi's contact information.
Has Francesco Bianchi been buying or selling shares of LivaNova?: Francesco Bianchi has not been actively trading shares of LivaNova during the last ninety days. Most recently, Francesco Bianchi sold 1,250 shares of the business's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $50.99, for a transaction totalling $63,737.50. Following the completion of the sale, the director now directly owns 7,522 shares of the company's stock, valued at $383,546.78. Learn More on Francesco Bianchi's trading history.
Who are LivaNova's active insiders?: LivaNova's insider roster includes Francesco Bianchi (Director), Marco Dolci (SVP), Damien McDonald (CEO), Daniel Moore (Director), and Alfred Novak (Director). Learn More on LivaNova's active insiders.
Are insiders buying or selling shares of LivaNova?: During the last year, insiders at the sold shares 2 times. They sold a total of 57,873 shares worth more than $3,467,346.03. The most recent insider tranaction occured on December, 11th when Director Francesco Bianchi sold 1,250 shares worth more than $63,737.50. Insiders at LivaNova own 0.3% of the company. Learn More about insider trades at LivaNova.
Information on this page was last updated on 12/11/2024.

Francesco Bianchi Insider Trading History at LivaNova

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/11/2024	Sell	1,250	$50.99	$63,737.50	7,522
5/23/2018	Sell	1,830	$83.81	$153,372.30

Francesco Bianchi Buying and Selling Activity at LivaNova

LivaNova Company Overview

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Today's Range

Now: $35.46

$34.75

$35.57

50 Day Range

MA: $39.58

$33.85

$49.50

2 Week Range

Now: $35.46

$32.48

$64.48

Volume

390,562 shs

Average Volume

626,167 shs

Market Capitalization

$1.93 billion

P/E Ratio

84.43

Dividend Yield

N/A

Beta

0.9